Sogandji Nihal, Stevenson Anna, Luo Michael Y, Qi Gao, Maude Richard J
School of Clinical Medicine, University of Cambridge, Addenbrooke's Hospital, Hills Rd, Cambridge, CB2 0SP, UK.
Jiangsu Institute of Parasitic Diseases, Meiyuan Yangxiang 117, Wuxi, China.
Malar J. 2024 Dec 18;23(1):371. doi: 10.1186/s12936-024-05200-w.
The 1-3-7 approach to eliminate malaria was first implemented in China in 2012. It has since been expanded to multiple countries, but no systematic review has examined the evidence for its use. A systematic review was conducted aiming to evaluate the impact and effectiveness of the strategy and identify key challenges and variations in its implementation across different countries.
PUBMED, Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, CABS Abstracts, LILACS, Global Health, Medrxiv, Biorxiv were searched for all studies containing 1-3-7 and articles included if they contained information on 1-3-7 impact, effectiveness, challenges and/or adaptations for implementation in different countries.
31 studies were included from China (19), Thailand (6), Myanmar (2), Tanzania (1), Cambodia (1), India (1) and Vietnam (1). During 1-3-7 implementation, malaria cases in China decreased by 99.1-99.9%, in Thailand by 66.9% during 2013-19, 65,1% in Cambodia during 2015-17 and 30.3% in India during 2015-16, with some differences in implementation. It was not possible to separate the impact of 1-3-7 from that due to other contemporaneous interventions. Implementing the 1-3-7 policy was largely effective, with reporting within 1 day in 99.8-100% of individuals in China and 36-100% in other countries, investigation within 3 days in 81.5-99.4% in China and 79.4-100% in other countries, and foci investigation within 7 days in 90.1-100% in China and 83.2-100% in other countries. Adaptations to 1-3-7 were described in 5 studies, mostly adjustment of the timing and/or definitions of each component. Key challenges identified included those related to staffing, equipment, process, and patient-provided information.
Overall, the 1-3-7 approach was effectively implemented with a concomitant decrease in cases in malaria elimination settings, however, it was not possible to quantify impact as it was not implemented in isolation. Implementing adequate measures for testing, reporting, treatment, and containment is crucial for its success, which is dependent on the availability of resources, infrastructure, staffing, and consistent compliance across regions and throughout the year. However, achieving this nationally and maintaining compliance, especially at borders with malaria-affected countries, poses significant challenges.
消除疟疾的1-3-7策略于2012年首次在中国实施。此后已扩展到多个国家,但尚未有系统评价对其应用证据进行检验。开展了一项系统评价,旨在评估该策略的影响和效果,并确定其在不同国家实施过程中的关键挑战和差异。
检索了PUBMED、Cochrane对照试验中心注册库(CENTRAL)、MEDLINE、EMBASE、CABS文摘数据库、LILACS、全球健康、Medrxiv、Biorxiv,以查找所有包含1-3-7的研究,若文章包含有关1-3-7的影响、效果、挑战和/或在不同国家实施的适应性信息,则纳入其中。
纳入了来自中国(19项)、泰国(6项)、缅甸(2项)、坦桑尼亚(1项)、柬埔寨(1项)、印度(1项)和越南(1项)的31项研究。在1-3-7策略实施期间,中国的疟疾病例减少了99.1%-99.9%,泰国在2013-2019年期间减少了66.9%,柬埔寨在2015-2017年期间减少了65.1%,印度在2015-2016年期间减少了30.3%,不同国家在实施方面存在一些差异。无法将1-3-7的影响与同期其他干预措施的影响区分开来。实施1-3-7政策总体有效,中国99.8%-100%的个体在1天内报告,其他国家为36%-100%;中国81.5%-99.4%的个体在3天内开展调查,其他国家为79.4%-100%;中国90.1%-100%的个体在7天内开展疫点调查,其他国家为83.2%-100%。5项研究描述了对1-3-7的适应性调整,主要是对每个组成部分的时间安排和/或定义进行调整。确定的关键挑战包括与人员配备、设备、流程以及患者提供信息相关的挑战。
总体而言,1-3-7策略在疟疾消除环境中得到有效实施,病例随之减少,但由于并非单独实施,因此无法量化其影响。实施充分的检测、报告、治疗和控制措施对其成功至关重要,这取决于资源、基础设施、人员配备的可用性以及各地区全年的持续依从性。然而,在全国范围内实现这一点并维持依从性,尤其是在与疟疾流行国家接壤的边境地区,面临重大挑战。